Brief: Voyager Therapeutics Inc - Nathan Jorgensen Resigns As CFO Effective May 8, 2026
21/04/2026 23:24
April 21 (Reuters) - Voyager Therapeutics Inc VYGR.O: VOYAGER THERAPEUTICS INC - NATHAN JORGENSEN RESIGNS AS CFO EFFECTIVE MAY 8, 2026 - SEC FILING VOYAGER THERAPEUTICS INC - APPOINTS ROBIN SWARTZ AS PRINCIPAL FINANCIAL OFFICER AND TREASURER EFFECTIVE MAY 8, 2026 - SEC FILING VOYAGER THERAPEUTICS INC - APPOINTS AMY QUINLAN AS PRINCIPAL ACCOUNTING OFFICER EFFECTIVE MAY 8, 2026 - SEC FILING Source text: [ID:n0001104659-26-045997] Further company coverage: VYGR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview